Clinical Textbook of Addictive Disorders.pdf
This state-of-the-science reference and text has given thousands of practitioners and students a strong foundation in understanding and treating addictive disorders. Leading experts address the neurobiology of addictions and review best practices in assessment and diagnosis. Specific substances of abuse are examined in detail, with attention to real-world clinical considerations. Issues in working with particular populations--including polysubstance abusers, culturally diverse patients, older adults, chronic pain sufferers, and others--are explored. Chapters summarize the theoretical and empirical underpinnings of widely used psychosocial and pharmacological treatments and clearly describe clinical techniques. New to This Edition *Incorporates a decade's worth of major advances in research and clinical practice. *Updated for DSM-5. *Many new authors; extensively revised with the latest information on specific biological mechanisms, substances, populations, and treatments. *Chapter on motivational interviewing.
"The book enriches the reader's understanding of drugs, their interactions, and ways to enhance screening and diagnosis, including how to overcome interview barriers when working with alcohol and drug users. There is good coverage of brain processes associated with substance use and their implications for treatment. The figures and tables contribute greatly to understanding each chapter. This would be a useful text for my graduate-level Addictions course; I would also recommend it as a supplementary reference in my undergraduate Mental Health course."--Cynthia Bostick, PMHCNS-BC, PhD, School of Nursing, California State University, Dominguez Hills "This book is unique in providing high-quality, comprehensive, and up-to-date coverage of all major topics in addictions, with broad applicability for training psychiatrists, clinical psychologists, and other mental health professionals. It is an excellent text for graduate or other professional courses in assessment and treatment of substance use disorders."--Stephen A. Maisto, PhD, Department of Psychology, Syracuse University "This book is ideal for therapists and researchers, as well students and trainees new to the field. Science and clinical practice issues are presented in a balanced and inclusive manner. Now in its fourth edition, the volume retains all of its originally positive features and adds timely and new information essential to better understanding and treating addictions."--Nancy Petry, PhD, Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine "This extraordinarily well-written, clinically relevant, evidence-based work provides guidance and clarity to treatment professionals. Thousands of patients and practitioners will benefit from its contents, and treatment outcomes will be greatly improved."--Louis E. Baxter, Sr., MD, FASAM, Executive Medical Director, Professional Assistance Program of New Jersey, Inc.; past president, American Society of Addiction Medicine
Avram H. Mack, MD, is Professor of Clinical Psychiatry at Georgetown University School of Medicine and a psychiatrist at Georgetown University Hospital. He is the director of medical student education in Georgetown s Department of Psychiatry and leads several multidisciplinary patient safety initiatives. Dr. Mack's interests include patient safety, substance use disorders, and forensic psychiatry. He is board certified in General Psychiatry, Child and Adolescent Psychiatry, Forensic Psychiatry, and Addiction Medicine. A past president of the Washington Psychiatric Society, he served on the board of the American Psychiatric Association and on the Impaired Physicians Committee of the Medical Society of the District of Columbia. He presents, publishes, and testifies extensively regarding substance abuse. Kathleen T. Brady, MD, PhD, a board-certified psychiatrist, is Distinguished University Professor and Associate Provost for Clinical and Translational Science at the Medical University of South Carolina. Her interests include drug and alcohol abuse/addiction and comorbid conditions. Dr. Brady leads numerous research projects and has served as president of the American Academy of Addiction Psychiatry, a member of the Scientific Advisory Council of the National Institute of Drug Abuse, and a board member of the College on Problems of Drug Dependence. She has authored over 300 publications; presented at conferences, grand rounds, and symposia; and received numerous awards. Sheldon I. Miller, MD, until his death in 2011, was Emeritus Professor of Psychiatry and former Chairman of the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. Recognized as a national leader in addiction psychiatry, he was the author of more than 100 publications. He was Editor-in-Chief of the" American Journal on Addictions" and was a founder of the American Academy of Addiction Psychiatry. Dr. Miller served on the Board of Directors of the Accreditation Council for Graduate Medical Education and the American Board of Emergency Medicine. He was a Distinguished Fellow of the American Psychiatric Association and a member of the Group for the Advancement of Psychiatry. Richard J. Frances, MD, maintains a private practice in New York, and was instrumental in the recognition of addiction psychiatry as a medical subspecialty. Board certified in Psychiatry and Addiction Psychiatry, he was a founder and the first president of the American Academy of Addiction Psychiatry. He has held leadership positions at New York Hospital--Cornell Medical Center and was president and medical director of Silver Hill Hospital. Dr. Frances is Clinical Professor of Psychiatry at New York University School of Medicine and Adjunct Professor at Rutgers New Jersey Medical School, and was director of education at the University of Medicine and Dentistry of New Jersey (now part of the Rutgers School of Biomedical and Health Sciences). He has a special interest in addiction, with a focus on impaired professionals."
I. Foundations of Addiction 1. The Neurobiology of Substance Dependence: Implications for Treatment, Thomas R. Kosten & Colin N. Haile 2. Historical and Social Context of Psychoactive Substance Disorders, Joseph Westermeyer II. Assessment of Addiction 3. Diagnostic Assessment in Substance Abusers, Deborah Hasin & Bari Kilcoyne 4. Laboratory Testing for Substances of Abuse, D. Andrew Baron & David A. Baron III. Substances of Abuse 5. Alcohol, Ed Nace 6. Nicotine Dependence, David Kalman, Amy Harrington, Joseph DiFranza, Lori Pbert, & Douglas Ziedonis 7. Opiate Misuse and Dependence, Sudie E. Back, Jenna L. McCauley, Kelly S. Barth, & Kathleen T. Brady 8. Cannabis, Alicia R. Murray & Frances R. Levin 9. Hallucinogens and Inhalants, Stephen Ross & Avram H. Mack 10. Caffeine, Laura M. Juliano & Greta Bielacyzc Raglan 11. Stimulants, Richard Rawson, Larissa Mooney, & Walter Ling 12. Cocaine, Evaristo Akerele & Niru Nahar 13. Sedatives/Hypnotics and Benzodiazepines, Robert L. DuPont, William M. Greene, & Caroline M. DuPont IV. Special Populations 14. Polysubstance Use, Abuse, and Dependence, Richard N. Rosenthal, Petros Levounis, & Abigail J. Herron 15. Co-Occurring Substance Use Disorders and Other Psychiatric Disorders, Benjamin C. Silverman, Lisa M. Najavits, Roger D. Weiss 16. Pathological Gambling and Other "Behavioral" Addictions, Liana R. N. Schreiber, Marc N. Potenza, & Jon E. Grant 17. Substance Abuse in Minority Populations, John Franklin 18. Addiction in the Workplace, Laurence Westreich 19. Forensic Approaches to Substances of Abuse, Avram H. Mack 20. Patients with Chronic Pain and Opioid Misuse, Deborah L. Haller & Sidney H. Schnoll 21. Older Adults and Substance Use, Steve Koh, Robert Gorney, Nicolas Badre, & Dilip Jeste 22. HIV/AIDS and Substance Use Disorders, Cheryl Ann Kennedy & Steven J. Schleifer 23. Women and Substance Abuse, Dawn E. Sugarman, Christina Brezing, & Shelly F. Greenfield 24. Substance Use Disorders in Adolescence, Oscar G. Bukstein & Yifrah Kaminer V. Treatments for Addictions 25. Matching and Differential Therapies: Providing Substance Abusers with Appropriate Treatment, Kathleen M. Carroll & Brian D. Kiluk 26. Individual Psychodynamic Psychotherapy, Lance M. Dodes & Edward J. Khantzian 27. Cognitive Therapy, Judith S. Beck, Bruce S. Liese, & Lisa M. Najavits 28. Group Therapy, Self-Help Groups, and Network Therapy, Marc Galanter 29. Family Therapy Approaches to Substance Use, Edward Kaufman 30. Motivational Interviewing in Psychiatry with Substance Abusing Clients, Jennifer L. Smith, Kenneth M. Carpenter, R. Morgan Wain, & Edward V. Nunes 31. Dialectical Behavior Therapy for Individuals with Borderline Personality Disorder and Substance Use Disorders, Dorian Hunter, M. Zachary Rosenthal, Thomas R. Lynch, and Marsha M. Linehan 32. Psychopharmacological Treatments, Larissa J. Mooney & Elinore F. McCance-Katz Index